Frédéric Ooms

899 total citations
25 papers, 705 citations indexed

About

Frédéric Ooms is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Frédéric Ooms has authored 25 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Frédéric Ooms's work include Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (3 papers) and Analytical Chemistry and Chromatography (3 papers). Frédéric Ooms is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (3 papers) and Analytical Chemistry and Chromatography (3 papers). Frédéric Ooms collaborates with scholars based in Belgium, United States and Switzerland. Frédéric Ooms's co-authors include Bernard Testa, Johan Wouters, Pierre‐Alain Carrupt, Angelo Carotti, Francesco Leonetti, Marco Catto, Cosimo Altomare, Jean C. Shih, Kai Chen and Pierre‐Alain Carrupt and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Frédéric Ooms

24 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Ooms Belgium	10	339	252	210	194	52	25	705
Modesto de Candia Italy	19	399 1.2×	315 1.3×	273 1.3×	216 1.1×	57 1.1×	63	885
Nicola Gambacorta Italy	18	301 0.9×	292 1.2×	305 1.5×	310 1.6×	36 0.7×	61	852
Carmen Terán Spain	21	738 2.2×	213 0.8×	471 2.2×	364 1.9×	38 0.7×	74	1.3k
Erçin Erciyas Türkiye	17	461 1.4×	226 0.9×	234 1.1×	144 0.7×	42 0.8×	34	706
Jacques Joubert South Africa	20	611 1.8×	292 1.2×	368 1.8×	184 0.9×	58 1.1×	63	1.1k
Marija R. Popović-Nikolić Serbia	7	177 0.5×	138 0.5×	279 1.3×	208 1.1×	63 1.2×	16	614
Jeffrey Sterling Israel	15	536 1.6×	182 0.7×	334 1.6×	66 0.3×	55 1.1×	19	998
José A. Fontenla Spain	16	306 0.9×	130 0.5×	231 1.1×	75 0.4×	30 0.6×	36	610
Bernard Refouvelet France	17	592 1.7×	500 2.0×	247 1.2×	294 1.5×	22 0.4×	48	1.1k
Giulio Ferino Italy	15	195 0.6×	140 0.6×	220 1.0×	99 0.5×	27 0.5×	27	508

Countries citing papers authored by Frédéric Ooms

Since Specialization

Citations

This map shows the geographic impact of Frédéric Ooms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Ooms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Ooms more than expected).

Fields of papers citing papers by Frédéric Ooms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Ooms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Ooms. The network helps show where Frédéric Ooms may publish in the future.

Co-authorship network of co-authors of Frédéric Ooms

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Ooms. A scholar is included among the top collaborators of Frédéric Ooms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Ooms. Frédéric Ooms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ooms, Frédéric, et al.. (2024). Entrepreneurial neuroanatomy: Exploring gray matter volume in habitual entrepreneurs. Journal of Business Venturing Insights. 22. e00480–e00480. 3 indexed citations

Obschonka, Martin, Denis A. Grégoire, Boris Nikolaev, et al.. (2024). Artificial Intelligence and Entrepreneurship: A Call for Research to Prospect and Establish the Scholarly AI Frontiers. Entrepreneurship Theory and Practice. 49(3). 620–641. 10 indexed citations

Ooms, Frédéric, Bernard Surlemont, Jitka Annen, Rajanikant Panda, & Steven Laureys. (2023). The Habitual Entrepreneur Brain – A Voxel Based Morphometry Study. Academy of Management Proceedings. 2023(1). 1 indexed citations

Ooms, Frédéric, Jitka Annen, Rajanikant Panda, et al.. (2023). Advancing (Neuro)Entrepreneurship Cognition Research Through Resting-State fMRI: A Methodological Brief. Entrepreneurship Theory and Practice. 48(2). 719–741. 6 indexed citations

Hoveyda, Hamid R., Graeme L. Fraser, Guillaume Dutheuil, et al.. (2018). N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model. Bioorganic & Medicinal Chemistry. 26(18). 5169–5180. 2 indexed citations

Ferain, Thierry, Hamid R. Hoveyda, Frédéric Ooms, et al.. (2011). Agonist-Induced Internalization of CC Chemokine Receptor 5 as a Mechanism to Inhibit HIV Replication. Journal of Pharmacology and Experimental Therapeutics. 337(3). 655–662. 17 indexed citations

Frédérick, Raphaël, Willy Dumont, Frédéric Ooms, et al.. (2006). Synthesis, Structural Reassignment, and Biological Activity of Type B MAO Inhibitors Based on the 5H-Indeno[1,2-c]pyridazin-5-one Core. Journal of Medicinal Chemistry. 49(12). 3743–3747. 35 indexed citations

Frédérick, Raphaël, Frédéric Ooms, Neal Castagnoli, et al.. (2005). (E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B. Acta Crystallographica Section C Crystal Structure Communications. 61(9). o531–o532. 4 indexed citations

Frédérick, Raphaël, Bernadette Norberg, F. Durant, Frédéric Ooms, & Johan Wouters. (2004). Three 5H-indeno[1,2-c]pyridazin-5-one derivatives, potent type-B monoamine oxidase inhibitors. Acta Crystallographica Section C Crystal Structure Communications. 60(9). o623–o626. 2 indexed citations

10.

Ooms, Frédéric, Raphaël Frédérick, F. Durant, et al.. (2003). Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative. Bioorganic & Medicinal Chemistry Letters. 13(1). 69–73. 13 indexed citations

11.

Ooms, Frédéric, P. Weber, Pierre‐Alain Carrupt, & Bernard Testa. (2002). A simple model to predict blood–brain barrier permeation from 3D molecular fields. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1587(2-3). 118–125. 64 indexed citations

12.

Chen, Kai, et al.. (2002). Analysis of Conserved Active Site Residues in Monoamine Oxidase A and B and Their Three-dimensional Molecular Modeling. Journal of Biological Chemistry. 277(19). 17209–17216. 86 indexed citations

13.

Ooms, Frédéric, Johan Wouters, Géraldine Bouchard, et al.. (2002). Exploration of the Pharmacophore of 3-Alkyl-5-arylimidazolidinediones as New CB₁ Cannabinoid Receptor Ligands and Potential Antagonists: Synthesis, Lipophilicity, Affinity, and Molecular Modeling.. Journal of Medicinal Chemistry. 45(21). 4799–4799. 1 indexed citations

14.

Ooms, Frédéric, Johan Wouters, Géraldine Bouchard, et al.. (2002). Exploration of the Pharmacophore of 3-Alkyl-5-Arylimidazolidinediones as New CB₁Cannabinoid Receptor Ligands and Potential Antagonists: Synthesis, Lipophilicity, Affinity, and Molecular Modeling. Journal of Medicinal Chemistry. 45(9). 1748–1756. 37 indexed citations

15.

Wouters, Johan & Frédéric Ooms. (2001). Small Molecule Crystallography in Drug Design. Current Pharmaceutical Design. 7(7). 529–545. 7 indexed citations

16.

Ooms, Frédéric, Pierre‐Alain Carrupt, Bernard Testa, et al.. (2001). Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase. Journal of Medicinal Chemistry. 44(19). 3195–3198. 256 indexed citations

17.

Ooms, Frédéric. (2000). Molecular Modeling and Computer Aided Drug Design. Examples of their Applications in Medicinal Chemistry. Current Medicinal Chemistry. 7(2). 141–158. 105 indexed citations

18.

Ooms, Frédéric, Johan Wouters, Sonia Collin, et al.. (1998). Molecular lipophilicity potential by clip, a reliable tool for the description of the 3D distribution of lipophilicity: Application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(11). 1425–1430. 8 indexed citations

19.

Wouters, Johan, et al.. (1997). Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compound. European Journal of Medicinal Chemistry. 32(9). 721–730. 25 indexed citations

20.

Wouters, Johan, et al.. (1997). 2-Oxazolidinone. Acta Crystallographica Section C Crystal Structure Communications. 53(7). 895–897. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact